SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients-Reference-Cited by-同舟云学术

SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients

Published:2013-05 Issue:2 Volume:129 Page:298-303
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Antonsen Sofie Leisby,Loft Annika,Fisker Rune,Nielsen Anne Lerberg,Andersen Erik Søgaard,Høgdall Estrid,Tabor Ann,Jochumsen Kirsten,Fagö-Olsen Carsten L.,Asmussen Jon,Berthelsen Anne Kiil,Christensen Ib Jarle,Høgdall Claus

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference20 articles.

1. Cancer statistics, 2007;Jemal;CA Cancer J Clin,2007

2. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study;Creasman;Cancer,1987

3. Molecular imaging of cancer with positron emission tomography;Gambhir;Nat Rev Cancer,2002

4. Prognostic significance of SUVmax (maximum standardized uptake value) measured by [(1)(8)F]FDG PET/CT in endometrial cancer;Kitajima;Eur J Nucl Med Mol Imaging,2012

5. Preoperative risk stratification using (18)F-FDG PET/CT in women with endometrial cancer;Lee;Nuklearmedizin,2011

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery;Cureus;2024-01-28

2. Revisión sistemática sobre el papel de la 18F-FDG PET/TC preoperatoria para el pronóstico y la estratificación de riesgo en pacientes con cáncer de endometrio;Revista Española de Medicina Nuclear e Imagen Molecular;2023-01

3. The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer;Nuclear Medicine Communications;2022-12-16

4. A case of primary small cell neuroendocrine carcinoma of the uterus;Radiology Case Reports;2022-11

5. PET imaging in cervical and uterine cancers;Nuclear Medicine and Molecular Imaging;2022